GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Endo Inc (OTCPK:NDOI) » Definitions » FCF Yield %

Endo (NDOI) FCF Yield % : -30.23 (As of Mar. 03, 2025)


View and export this data going back to 2024. Start your Free Trial

What is Endo FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Endo's Trailing 12-Month Free Cash Flow is $-654 Mil, and Market Cap is $2,165 Mil. Therefore, Endo's FCF Yield % for today is -30.23%.

The historical rank and industry rank for Endo's FCF Yield % or its related term are showing as below:

NDOI' s FCF Yield % Range Over the Past 10 Years
Min: -41.82   Med: 0   Max: 0
Current: -30.23


NDOI's FCF Yield % is ranked worse than
89.83% of 1032 companies
in the Drug Manufacturers industry
Industry Median: 0.165 vs NDOI: -30.23

Endo's FCF Margin % for the quarter that ended in Sep. 2024 was 0.00%.


Endo FCF Yield % Historical Data

The historical data trend for Endo's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Endo FCF Yield % Chart

Endo Annual Data
Trend
FCF Yield %

Endo Quarterly Data
Jun23 Sep23 Apr24 Sep24
FCF Yield % - - - -

Competitive Comparison of Endo's FCF Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Endo's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Endo's FCF Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Endo's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Endo's FCF Yield % falls into.



Endo FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Endo's FCF Yield % for the fiscal year that ended in . 20 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
= /
=N/A%

Endo's annualized FCF Yield % for the quarter that ended in Sep. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=0 * 4 / 1940.45488
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Endo FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Endo FCF Yield % Related Terms

Thank you for viewing the detailed overview of Endo's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Endo Business Description

Traded in Other Exchanges
N/A
Address
1400 Atwater Drive, Malvern, PA, USA, 19355
Endo Inc is a diversified specialty pharmaceutical company that develops, manufactures, markets and sells a broad portfolio of pharmaceutical products across four reportable segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals and International Pharmaceuticals.